Oncostatin M gene therapy attenuates liver damage induced by dimethylnitrosamine in rats

American Journal of Pathology

Volumn 171, Issue 3, 2007, Pages 872-881

  Hamada, Tetsuhiro ^a   Sato, Ayuko ^a   Hirano, Tadamichi ^a   Yamamoto, Takashi ^b   Son, Gakuhei ^a   Onodera, Masayuki ^a   Torii, Ikuko ^a   Nishigami, Takashi ^a   Tanaka, Minoru ^c   Miyajima, Atsushi ^c   Nishiguchi, Shuhei ^a   Fujimoto, Jiro ^a   Tsujimura, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COMPLEMENTARY DNA; DIMETHYLNITROSAMINE; HYALURONIC ACID; ONCOSTATIN M; VIRUS VECTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTENUATION; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; FIBROSIS; GENE THERAPY; HISTOLOGY; INFLAMMATORY CELL; KUPFFER CELL; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PRESERVATION; LIVER REGENERATION; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; VIRUS ENVELOPE; VIRUS HEMAGGLUTINATION;

EID: 34548829097     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.060972     Document Type: Article

References (50)

1. Fausto N, Laird AD, Webber EM: Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995, 9:1527-1536
2. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997, 276:60-66
3. Lindroos PM, Zarnegar R, Michalopoulos GK: Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991, 13: 743-750
4. Rubin RA, O'Keefe EJ, Earp HS: Alteration of epidermal growth factor-dependent phosphorylation during rat liver regeneration. Proc Natl Acad Sci USA 1982, 79:776-780
5. Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N: Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 1993, 18:1422-1431
6. Yamada Y, Fausto N: Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am J Pathol 1998, 152:1577-1589
7. Webber EM, Bruix J, Pierce RH, Fausto N: Tumor necrosis factor primes hepatocytes for DNA replication in the rat. Hepatology 1998, 28:1226-1234
8. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996, 274:1379-1383
9. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R: Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000, 31:149-159
10. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988, 81:414-419
11. Okano J, Shiota G, Kawasaki H: Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 1997, 26:1241-1249
12. Kosai K, Matsumoto K, Funakoshi H, Nakamura T: Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999, 30:151-159
13. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 1997, 26:81-89
14. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999, 5:226-230
15. Gómez-Lechón MJ: Oncostatin M: signal transduction and biological activity. Life Sci 1999, 65:2019-2030
16. Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15:797-819
17. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara T: Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 2000, 11:177-183
18. Tanaka M, Miyajima A: Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 2003, 149:39-52
19. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A: Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor β subunit. Blood 1999, 93:804-815
20. Kamiya A, Kinoshita T, Ito Y, Matsui T, Morikawa Y, Senba E, Nakashima K, Taga T, Yoshida K, Kishimoto T, Miyajima A: Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 1999, 18:2127-2136
21. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A: Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 2004, 39:635-644
22. Okaya A, Kitanaka J, Kitanaka N, Satake M, Kim Y, Terada K, Sugiyama T, Takemura M, Fujimoto J, Terada N, Miyajima A, Tsujimura T: Oncostatin M inhibits proliferation of rat oval cells, OC15-5, inducing differentiation into hepatocytes. Am J Pathol 2005, 166:709-719
23. Kaneda Y, Tabata Y: Non-viral vectors for cancer therapy. Cancer Sci 2006, 97:348-354
24. Pritchard DJ, Butler WH: Apoptosis - the mechanism of cell death in dimethylnitrosamine-induced hepatotoxicity. J Pathol 1989, 158: 253-260
25. Horn TL, Bhattacharjee A, Schook LB, Rutherford MS: Altered hepatic mRNA expression of apoptotic genes during dimethylnitrosamine exposure. Toxicol Sci 2000, 57:240-249
26. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ: Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 1986, 83: 9739-9743
27. Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF: Regulation of inflammatory responses by oncostatin M. J Immunol 1999, 162:5547-5555
28. Kinoshita T, Sekiguchi T, Xu MJ, Ito Y, Kamiya A, Tsuji K, Nakahata T, Miyajima A: Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc Natl Acad Sci USA 1999, 96:7265-7270
29. Wisse E, De Zanger RB, Charels K, Van Der Smissen P, McCuskey RS: The liver sieve: considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of Disse. Hepatology 1985, 5:683-692
30. Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, Fujimoto J: Nuclear factor κB decoy oligodeoxynucleotides prevent endotoxin-induced fetal liver failure in a murine model. Hepatology 2003, 38:335-344
31. Brown TJ, Liu J, Brashem-Stein C, Shoyab M: Regulation of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor expression by oncostatin M. Blood 1993, 82:33-37
32. Brown TJ, Rowe JM, Liu JW, Shoyab M: Regulation of IL-6 expression by oncostatin M. J Immunol 1991, 147:2175-2180
33. Yao L, Pan J, Setiadi H, Patel KD, McEver RP: Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996, 184:81-92
34. Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, McIntyre TM: Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 1997, 100:158-168
35. Richards CD, Shoyab M, Brown TJ, Gauldie J: Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture. J Immunol 1993, 150:5596-5603
36. Richards CD, Langdon C, Botelho F, Brown TJ, Agro A: Oncostatin M inhibits IL-1-induced expression of IL-8 and granulocyte-macrophage colony-stimulating factor by synovial and lung fibroblasts. J Immunol 1996, 156:343-349
37. Kerr C, Langdon C, Graham F, Gauldie J, Hara T, Richards CD: Adenovirus vector expressing mouse oncostatin M induces acute-phase proteins and TIMP-1 expression in vivo in mice. J Interferon Cytokine Res 1999, 19:1195-1205
38. Sanchez AL, Langdon CM, Akhtar M, Lu J, Richards CD, Bercik P, McKay DM: Adenoviral transfer of the murine oncostatin M gene suppresses dextran-sodium sulfate-induced colitis. J Interferon Cytokine Res 2003, 23:193-201
39. Song HY, Jeon ES, Jung JS, Kim JH: Oncostatin M induces proliferation of human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell Biol 2005, 37:2357-2365
40. Cohen M, Marchand-Adam S, Lecon-Malas V, Marchal-Somme J, Boutten A, Durand G, Crestani B, Dehoux M: HGF synthesis in human lung fibroblasts is regulated by oncostatin M. Am J Physiol 2006, 290:L1097-L1103
41. Stepniak E, Ricci R, Eferl R, Sumara G, Sumara I, Rath M, Hui L, Wagner EF: c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. Genes Dev 2006, 20:2306-2314
42. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T: Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996, 5:449-460
43. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R: lnterleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 2001, 276:26605-26613
44. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, Okuyama T, Takeda K, Akira S, Ogino T, Irani K, Ozaki M: Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003, 112:989-998
45. Jézéquel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F: A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 1987, 5:174-181
46. Jézéquel AM, Mancini R, Rinaldesi ML, Ballardini G, Fallani M, Bianchi F, Orlandi F: Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 1989, 8:42-52
47. Myers MJ, Schook LB: Immunotoxicity of nitrosamines. Experimental Immunotoxicology. Edited by RJ Smialowicz, MP Holsapple. Boca Raton, CRC Press, 1996, pp 351-366
48. Jin YL, Enzan H, Kuroda N, Hayashi Y, Toi M, Miyazaki E, Hamauzu T, Hiroi M, Guo LM, Shen ZS, Saibara T: Vascularization in tissue remodeling after rat hepatic necrosis induced by dimethylnitrosamine. Med Mol Morphol 2006, 39:33-43
49. Li W, Liang X, Kellendonk C, Poli V, Taub R: STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 2002, 277:28411-28417
50. Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A: Expression of oncostatin M and its receptors in normal and cirrhotic human liver. J Hepatol 2005, 43:893-900